Transcatheter Mitral Valve Repair and Replacement and Edwards Lifesciences' New CE Mark

Edwards Lifesciences has once again made a significant move in the transcatheter mitral valve repair and replacement market. On the heels of its CE Mark approval for the Sapien M3 Mitral Valve Replacement System, the company is expanding its portfolio and bringing new hope to patients with mitral regurgitation (MR). This blog is originally published here: https://shorturl.at/Anw0l

The Weekly Recap 4/18/25: LSI Alumni Achievements Driving Medtech and Healthtech Forward

Received FDA Breakthrough Device Designation for its vCLAS™ Cryoablation System, a novel therapy for recurrent, drug-refractory, sustained monomorphic ventricular tachycardia. The designation validates Adagio’s proprietary ULTC technology and supports priority FDA review as the company advances its pivotal FULCRUM-VT study toward pre-market approval. This blog is originally Published here: https://shorturl.at/N3ECV

The Memo | Special Edition: Medtech Trailblazers Headed to LSI Asia ‘25

As we gear up for LSI Asia ‘25 this June in Singapore, we’re spotlighting six standout innovators previously featured in The Memo—each of whom will be taking the stage to share the latest updates on their mission, technology, and milestones. This special edition recap brings their stories together in one place and gives you a preview of what to expect at LSI Asia ‘25. This blog is originally published here: https://shorturl.at/MMUxz

Cover Story: Solving Wicked Problems at the Intersection of Healthcare and Technology - Insights from Intuitive Foundation’s Catherine Mohr, MD

Dr. Catherine Mohr shares her journey with Intuitive Surgical as the surgical robotics leader evolved as a “29-year overnight success,” and offers lessons on how to approach what she calls the wicked problems in healthcare and medtech. Now leading the Intuitive Foundation, she’s focused on solutions that go beyond technology, ensuring innovation meets real-world needs—for example addressing the global surgical training gap in emerging markets to save patient lives. For more details visit here: https://shorturl.at/y9mrS

The Memo: Solenic Medical Transforming PJI Treatment with Magnetic Precision

Under the direction of CEO and Chairman James Lancaster, Solenic Medical is pioneering a radically noninvasive approach to a devastating healthcare challenge: prosthetic joint infections (PJIs). With a platform that uses alternating magnetic fields to generate targeted heat on metallic implants, Solenic offers a new way to disrupt bacterial biofilms—without surgery, synergistic with the standard of care use of antibiotics, and without compromise. For more information visit here: https://shorturl.at/imHTI